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Tissue-resident γδ intraepithelial lymphocytes (IELs) orchestrate innate and adaptive immune
responses to maintain intestinal epithelial barrier integrity. Epithelia-specific butyrophilin-like
(Btnl) molecules induce perinatal development of distinct Vγ TCR+ IELs, however, the
mechanisms that control γδ IEL maintenance within discrete intestinal segments are unclear.
Here, we show that Btnl2 suppressed homeostatic proliferation of γδ IELs preferentially in the
ileum. High throughput transcriptomic characterization of site-specific Btnl2-KO γδ IELs
reveals that Btnl2 regulated the antimicrobial response module of ileal γδ IELs. Btnl2 defi-
ciency shapes the TCR specificities and TCRγ/δ repertoire diversity of ileal γδ IELs. During
DSS-induced colitis, Btnl2-KO mice exhibit increased inflammation and delayed mucosal
repair in the colon. Collectively, these data suggest that Btnl2 fine-tunes γδ IEL frequencies
and TCR specificities in response to site-specific homeostatic and inflammatory cues. Hence,
Btnl-mediated targeting of γδ IEL development and maintenance may help dissect their
immunological functions in intestinal diseases with segment-specific manifestations.
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T issue-resident intraepithelial lymphocytes (IELs) representa heterogenous population of antigen-experienced immunecells in the intestinal epithelium that are involved in the
maintenance of gut homeostasis1,2. In particular, IELs expressing
αβ T cell receptors (TCRs) are poised for mounting pathogen-
specific memory responses, while those possessing γδ TCRs
strengthen tight junctions and orchestrate innate and adaptive
immunity during homeostasis, inflammation, and infection1–6.
Interactions between intestinal epithelial cells (IECs) and γδ IELs
influence IEL development and function7,8. Notably, recent stu-
dies emphasized that anatomical segregation could drive gut
segment-specific immunity9–11, including functionally distinct γδ
IEL immune responses to chemically-induced and pathogen-
induced epithelial injury5,12–14. However, the mechanisms that
regulate γδ IEL development and maintenance in response to the
local antigenic environment remain poorly understood.
Recent studies provided some evidence that IEC-specific
butyrophilin-like (Btnl) molecules induce perinatal expansion
and maturation of distinct Vγ TCR+ IELs5,7,15–17. Indeed,
intestinal γδ IELs predominantly express Vγ7 in mice and Vγ4 in
humans that persist throughout the life of the host5,7. γδ IELs
continuously sample both self and bacterial antigens from the
local environment to customize their TCR specificities5,16.
Moreover, the contributions of Btnl molecules to shaping γδ TCR
repertoire diversity and regulating the distribution and function
of γδ IEL subsets across intestinal compartments18,19 remain to
be elucidated and may inform our understanding of the com-
partmentalized immune responses observed in the intestine9,11,14.
Btn/Btnl proteins are members of B7 immunoglobulin-
superfamily and analogous to other costimulatory and coin-
hibitory molecules (e.g., CD80, CD86, PDL1, and PDL2) have
been shown to modulate αβ T cell immune functions, including
inhibition of CD4+ T and CD8+ T cell activation, proliferation
and cytokine production, induction of regulatory T (Treg) cells
and blockade of antigen-specific proinflammatory responses20–27.
Btnl2, a member of the Btnl family, has been shown to induce
Treg differentiation and suppress T cell activation and pro-
liferation in vitro25. Accordingly, Btnl2-KO chimera mice dis-
played increased susceptibility in a mouse model of experimental
cerebral malaria and higher frequencies of peripheral CD4+ T
and CD8+ T cells indicating a potential role for Btnl2 in dam-
pening infection-elicited T cell immune responses in vivo28. Btnl2
is highly enriched in villous IECs across different intestinal
compartments and its expression is reported to be altered by
inflammatory cues such as epithelial injury and tumor
burden21,29–32. In particular, Btnl2 mRNA levels were increased
in the colon of Mdr1a-KO colitic mice and decreased in human
colon tumors29,32. Furthermore, truncating single nucleotide
polymorphisms (SNPs) of BTNL2 were associated with ulcerative
colitis (UC) and chronic sarcoidosis, independent of linkage
disequilibrium (LD) with HLA21,29–31. The role of Btnl2 in reg-
ulating intestinal immune responses during homeostasis and
inflammation and, particularly, in the induction and maintenance
of intestinal γδ IELs has not yet been addressed.
Here, we report the generation and characterization of Btnl2
knockout mice and identify a role for Btnl2 in regulating the fre-
quencies and phenotype of γδ IELs preferentially in the ileum at a
steady state. We found that γδ IELs derived from the ileum, but not
duodenum, of Btnl2-KO mice possess a dysregulated antibacterial
response module. By integrating RNA and single-cell TCR expression
data we identified distinct transcriptional signatures and greater TCR
repertoire diversity in ileal Btnl2-KO γδ IELs. Upon DSS challenge,
Btnl2-KO mice displayed enhanced colonic, but not ileal, intestinal
inflammation, and delayed mucosal repair. Collectively, our findings
suggest that context-dependent Btnl2 expression fine-tunes intestinal
immune responses to protect against epithelial injury.
Results
Btnl2 is preferentially expressed in small intestinal epithelial
cells. To determine the expression pattern of Btnl2 in the intestine
during homeostasis, we generated Btnl2-LacZ knock-in mice
henceforth referred to as Btnl2-KO mice (Fig. 1a). Consistent
with previous observations21,29, Btnl2 was predominantly
expressed in terminally differentiated IECs of the small intestine
(Fig. 1b). Importantly, unlike Btnl1, Btnl4, and Btnl67, Btnl2
expression was detected in duodenal Brunner’s glands and duo-
denal, jejunal, ileal, and colonic crypts, suggesting potential
divergent roles of different Btnls dictated by their region-specific
expression patterns (Fig. 1b). To further validate our observa-
tions, we measured Btnl2 mRNA levels in IECs derived from
terminally differentiated enterocytes isolated from the duodenum,
jejunum, ileum, and distal colon. Btnl2 was highly enriched in
duodenal IECs with a descending proximal-to-distal gradient,
such that Btnl2 expression in IECs isolated from the colon was
~5-fold lower than in the ileum of WT mice (Fig. 1c). Similarly,
BTNL2 transcripts were detected in the small intestine, but not
colon samples pooled from healthy human tissues30.
Given the close proximity of the Btnl2 gene to the H2 locus and
other Btnls33, we investigated the expression levels of several
adjacent genes in the IEC fraction isolated from duodenum,
jejunum, and ileum of Btnl2-KO and WT mice by bulk RNA-
sequencing. We did not observe any significant changes in H2-
Aa, H2-Ab1, H2-Eb1, Tap1/2, BC051142, Btnl4, Btnl5, Btnl6,
Notch4, and Ppt2 gene expression levels across different segments
of the small intestine, albeit Btnl2-KO mice displayed a trend
towards decreased levels of Btnl1 (Supplementary Figure 1),
indicating no significant coregulation of Btnl2 with adjacent genes
near the H2 locus. Altogether, our data confirm preferential
expression of Btnl2 in terminally differentiated enterocytes across
different segments of the small intestine suggesting a
compartment-specific function of Btnl2.
Btnl2-KO mice display increased frequencies of γδ IELs pre-
ferentially in the ileum. Under homeostatic conditions, Btnl2-
KO mice did not exhibit any adverse intestinal pathology, as
determined by body weight loss, increased epithelial sloughing,
and pro-inflammatory cytokines (Supplementary Figure 2a, b). In
addition, we did not observe any significant changes in genes
associated with differentiation and maturation of IECs34–41,
suggesting that IEC development and maintenance are not altered
in unchallenged Btnl2-KO mice (Supplementary Figure 2c).
In light of the developing paradigm implicating members
of Btnl/BTN/BTNL family in shaping the γδ T cell
compartment5,7,16,17,42,43 and intrigued by the selective expres-
sion pattern of Btnl2 in different segments of the small intestine,
we postulated Btnl2 deficiency might impact the maintenance of
γδ IEL subsets in different segments of the small intestine. To this
end, we isolated IELs from the duodenum, jejunum, and ileum of
adult Btnl2-KO and WT mice. Consistent with the previous
observations14,18,19, γδ IELs were found at ~3-fold higher
frequency in the duodenum compared to the ileum of WT mice
(30.7% vs. 8.62% in total cells, Fig. 2a-right panel), however
we observed that compared to WT littermates, Btnl2-KO mice
displayed a 30–40% increase in the frequency of γδ IELs in the
jejunum (27.1% vs. 20.1%) and ileum (12.8% vs. 8.6%), but not
duodenum (29.4% vs. 30.7%) (Fig. 2a). Notably, this increase was
observed predominantly in ileal CD8αα+ γδ IELs suggesting that
Btnl2 may suppress their proliferative capacity in situ (Fig. 2a). As
the number of Vγ7+ IELs have been reported to plateau in
11–16-week-old young adults7, we investigated whether the
observed effect of Btnl2 on the percentage of ileal γδ IELs
changed as mice approached middle adulthood. Previous work
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suggested that ileal γδ IEL frequencies, including CD8αα+ γδ
IELs, remain steady past 6 months of age in WT mice44. In
contrast, we observed that γδ IEL frequency was reduced by 50%
at 6 months of age in WT mice in our facility (39.5% vs. 17.1% in
total γδ IELs) (Fig. 2b, d). Conversely, αβ IEL frequency remained
relatively unchanged at 6 months of age suggesting that αβ IELs
actively maintain their levels, possibly through in situ expansion
(Fig. 2c). We found that γδ IELs were significantly increased in
the ileum of young adult (up to 4 months old) Btnl2-KO
compared to WT mice (36.9% vs. 22.3% in CD8αα+ γδ IELs),
while mature adult mice displayed similar levels of γδ IELs
(Fig. 2b, d). αβ IELs were not significantly altered in Btnl2-KO
mice during this time frame (Fig. 2c). As such, the Btnl2 effect in
young adult mice suggests it plays a role in γδ IEL maintenance
under homeostatic conditions. Notably, γδ T cells were observed
at comparable frequencies in the lamina propria (LP) of the
duodenum, jejunum, and ileum, mesenteric lymph nodes (mLN),
and Peyer’s Patches (PP) of Btnl2-KO and WT mice indicating
that Btnl2 exerts its function specifically on γδ CD8αα+ IELs
(Fig. 2e).
Prior studies had shown that recombinant Btnl2 can inhibit mLN
CD4+ T cell proliferation and promote Treg cell differentiation







































































Fig. 1 Btnl2 is preferentially expressed in small intestinal epithelial cells. a Schematic representation of the WT and targeted locus of Btnl2−/− mice.
hUb, human Ubiquitin promoter. b Beta-galactosidase and Neutral Red counterstaining in cryosections of segments of the small intestine (duodenum,
jejunum, and ileum) and colon of 15-week-old Btnl2-KO mice. Arrowheads indicate regions of duodenal glands and duodenal, jejunal, ileal, and colonic
crypts and villi with weak Btnl2-LacZ expression. Magnification is 20×; scale bar is 50 μm. c mRNA expression of Btnl2 in intestinal epithelial cells from
different segments of small intestine and colon of cohoused 7-week-old Btnl2-KO and WT mice (n= 5, each), normalized to β2m. Error bars represent
mean ± SEM. Significance is measured using multiple unpaired t-tests assuming similar SD, *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001,
significantly different from WT mice.
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Fig. 2 Btnl2-KO mice display increased frequencies of γδ IELs in the ileum. a Different segments of the small intestine were collected from cohoused
7–17-week-old Btnl2-KO and WT mice (n= 3–8, each) and processed for flow cytometry. Left panel-representative flow cytometry plots of γδ IELs in the
duodenum, jejunum, and ileum of cohoused 7-week-old Btnl2-KO and WT littermates. Displayed plots are gated on live TCRαβ- cells. Right panel-
frequencies of γδ IELs and CD8αα+ γδ IELs from 7–17-week-old Btnl2-KO and WT littermates. b Frequencies of ileal γδ IELs at different ages (n= 6–23
mice/group). Error bars represent mean ± SEM. Significance is measured by 2-way ANOVA with Sidak’s multiple comparison test, *p < 0.05, **p < 0.005.
c Frequencies of ileal αβ IELs at different ages (n= 6–23mice/group). Error bars represent mean ± SEM. Significance is measured by 2-way ANOVA.
d Ileum was collected from cohoused Btnl2-KO and WT littermates of different ages and intestinal intraepithelial lymphocytes (IELs) were isolated and
processed for flow cytometry. Left panel-representative flow cytometry plots of γδ IELs in the ileum of 12–17-week-old Btnl2-KO and WT littermates. Right
panel-frequencies of ileal γδ IELs from 12–17-week-old Btnl2-KO and WT littermates. Data are pooled from 3 independent experiments with 3–6mice/
group. Error bars represent mean ± SEM. Significance is measured using unpaired t-tests assuming similar SD, *p < 0.05, **p < 0.005, significantly different
from WT mice. e Frequencies of γδ T cells in lamina propria (LP), mesenteric lymph nodes (MLN), spleen, and Peyer’s Patches of 7–17-week-old Btnl2-KO
and WT littermates (n= 3–6mice/group).
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under certain activation conditions in vitro21,22,25,29. Nevertheless, we
observed similar frequencies of CD4+ T cells and FoxP3+ Tregs in
the ileal LP, mLNs, and PPs of Btnl2-KOmice. In addition, Btnl2-KO
mice exhibited comparable immune cell profiles across different
tissues emphasizing the specificity and localized effect of Btnl2 effects
in the intestine on jejunal and ileal γδ IELs (Supplementary
Figure 3a–c).
Btnl2 suppresses proliferation of jejunal/ileal γδ IELs. To
investigate the effects that Btnl2 exerted on jejunal and ileal γδ
IELs, we revisited its ability to suppress T cell proliferation. As
Btnl2 inhibitory function is dependent on concurrent TCR sti-
mulation and ligation with the putative Btnl2 receptor on CD4+
T cells in vitro21,22,25,29, we activated CFSE-labeled CD4+ T cells
in the presence of equimolar concentrations of plate-bound
Btnl2-mFc, Pdl1-mFc, Pdl2-mFc, or mFc (Supplementary Fig-
ure 4a). After 72 h of culture, we found that recombinant Btnl2
potently suppressed proliferation and activation of CD4+ T cells
similarly to Pdl1 and Pdl2, as evidenced by CFSE dilution and
greater than 40% decrease in cytokine production (Supplemen-
tary Figure 4b, c). In line with previous reports25, CD28 co-
stimulation rescued production of TNFα and IFNγ, but not IL-2
(Supplementary Figure 4c), which also coincided with ~50%
decrease in Btnl2 binding to its putative receptor on activated
CD4+ T cells (Supplementary Figure 4d).
We next sought to determine whether Btnl2 suppresses the
proliferation of γδ IELs in vitro (Supplementary Figure 5a). To obtain
comparable numbers to those from the duodenum, we pooled IELs
from the jejunum and ileum. Interestingly, duodenal CD8αα+ γδ
IELs showed greater proliferative capacity compared to their jejunal/
ileal counterparts indicating that duodenum and jejunal/ileal γδ IELs
may require different TCR and/or cytokine stimulation (Fig. 3a).
Recombinant Btnl2 and Pdl1 potently inhibited the proliferation of
both duodenal and jejunal/ileal CD8αα+ γδ IELs (Fig. 3a, b).
However, Btnl2 suppressive effect was 2-fold higher on jejunal/ileal
CD8αα+ γδ IEL proliferation compared to one observed for
duodenal CD8αα+ γδ IELs (Fig. 3b). Importantly, recombinant
Btnl2 failed to inhibit the proliferation of duodenal or jejunal/ileal
CD8αβ+ αβ IELs, suggesting that the Btnl2 putative receptor may not
be present on these cells (Fig. 3b). Contrary to previous reports
suggesting stronger responsiveness of Btnl1-KO γδ IELs to α-CD3
stimulation7, we found that duodenal and jejunal/ileal Btnl2-KO γδ
and αβ IELs exhibited equal proliferative capacity compared to their
WT counterparts, indicating that Btnl2 deficiency did not impair the
ability of IELs to respond to TCR and cytokine stimulation
(Supplementary Figure 5b). Moreover, recombinant Btnl2 similarly
inhibited the proliferation of Btnl2-KO and WT jejunal/ileal γδ IELs
in vitro (Fig. 3c). Btnl2-KO and WT jejunal/ileal γδ IELs also showed
comparable expression profiles of coinhibitory receptors (e.g. PD1)
and markers associated with tissue residence, maturation, and
activation (e.g. CD69, CD44, CD27, and CD122)7,45 (Supplementary
Figure 5c). Altogether, these data indicate that Btnl2 preferentially
suppresses jejunal/ileal CD8αα+ γδ IEL proliferation.
To determine the proliferative capacity of Btnl2-KO γδ IELs
in vivo, we measured BrdU incorporation in γδ IELs. As
previously reported46, high BrdU incorporation was observed in
WT CD8αα+ γδ IELs by day 3 (Fig. 3d, e). Notably, ileal Btnl2-
KO γδ IELs incorporated BrdU ~2-fold more than their WT
counterparts (9.86 ± 1.52 vs. 5.87 ± 1.18), emphasizing the
enhanced proliferative capacity of γδ IELs in the absence of Btnl2
(Fig. 3d, e). Overall, these observations indicate that Btnl2 may
serve as a γδ immune checkpoint molecule by limiting the
expansion of mature γδ IELs in the ileum and, potentially,
regulate their effector responses during the normal epithelial
lifespan.
Ileal Btnl2-KO γδ IELs display a subdued antibacterial
response module. To gain insights into the impact of Btnl2
deficiency on γδ IEL cytolytic potential, we performed tran-
scriptomic analysis of γδ IELs enriched from duodenum, jeju-
num, and ileum of 11-week-old cohoused Btnl2-KO and WT
mice at steady-state. Over 200 genes were significantly down-
regulated (FDR < 0.05 and fold change > 1.5) in ileal Btnl2-KO γδ
IELs compared to their WT counterparts (Fig. 4a), whereas only
Btnl2 was significantly decreased in duodenal and jejunal Btnl2-
KO γδ IELs (Fig. 4b). The top 50 downregulated genes included
signaling molecules (e.g. Raph1, Cyr61, Tspan8), transcriptional
regulators of cell proliferation and apoptosis (e.g. Id1, Pbx1,
Nupr1, Hoxb7), growth factors (e.g. Kitl, Wnt3, Fgfbp1), anti-
microbial molecules (e.g. Ifi27l2b, Ccl25, Gsdmc3/4) and different
classes of metabolic molecules (e.g. aminoacid-Mgst1, lipid-
Fabp6, Pnliprp2, sulfur-Sult1c2, Cth, carbonic anhydrases-Car8)
(Fig. 4a, b). Collectively, these observations hint at some decrease
in the metabolic function of ileal Btnl2-KO γδ IELs compared to
ileal WT γδ IELs.
In line with these findings, gene ontology enrichment analysis
revealed that the most significantly dysregulated biological
processes centered around bacterial tolerance and clearance,
emphasizing that ileal Btnl2-KO γδ IELs display an impaired
ability to secrete antimicrobial molecules at a steady-state
(Fig. 4c). Interferon-induced molecules and several members of
the α-defensin antimicrobial peptide family were found among
the genes significantly downregulated in ileal Btnl2-KO γδ IELs
compared to their WT counterparts (Fig. 4d). Hence, our findings
indicate that γδ IELs in the ileum, but not duodenum or jejunum,
may be specialized in secreting antibacterial molecules in
response to local microbial antigens.
Single-cell TCR sequencing highlights greater repertoire
diversity in Btnl2-KO γδ IELs. To determine whether the
downregulated antibacterial response module observed in ileal
Btnl2-KO γδ IELs related to an altered γ/δ TCR repertoire, we
performed unbiased single-cell TCR sequencing on duodenal,
jejunal and ileal γδ IELs from Btnl2-KO and WT mice. In total,
we sequenced 28,679 cells and reassembled 24,961 productive γ
chains and 24,515 productive δ chains. Among all sequenced
cells, 17,260 cells (60.2%) had paired γ and δ chains. We found
that TRGV and TRDV gene usage was comparable between Btnl2-
KO and WT γδ IELs in the duodenum, jejunum, and ileum
(Fig. 5a). TRGV7 gene usage averaged 50% of TCR γ chains,
consistent with the previous reports7, whereas TRDV2-2, TRDV5,
TRDV6D-1, and TRDV6D-2 genes were equally represented and
their combined gene usage surpassed 80% of TCR δ chains. Ileal
Btnl2-KO γδ IELs used the TRGV7 gene less frequently than their
WT counterparts (51.0% vs. 53.2%), however, they employed the
less common TRGV4 gene more frequently (11.5% vs. 8.6%;
Pearson’s chi-squared test, p= 1.78 × 10−7). Similarly, ileal Btnl2-
KO γδ IELs showed reduced usage of TRDV2-2 and TRDV6D-2
genes compared to their WT counterparts (23.2% vs. 25.3%;
21.9% vs. 26.2%, respectively), whereas usage of TRDV6D-1 gene
(18.6% vs. 13.4%) and of the less employed TRDV12 gene (1.52%
vs. 0.87%) increased.
To establish TCR γ chain and δ chain clonotypes, we identified
TCR γ and δ sequences encoded by the same V gene and J gene
segments with identical aminoacid sequences in the third
complementarity determining regions (CDR3). Using the R iNext
package47, we computed two metrics (Species richness and
Shannon diversity) to estimate TCR diversity for each sample.
Overall, ileal Btnl2-KO γδ IELs had consistently higher TCR γ
chain diversity than WT γδ IELs by both measurements in both
interpolated and extrapolated data. For example, we randomly
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Fig. 3 Btnl2 suppresses proliferation of jejunal/ileal γδ IELs. IELs were isolated from duodenum and jejunum/ileum of cohoused 12-week-old Btnl2-KO
and WT mice (n= 4–5, each), labeled with CFSE and stimulated with α-CD3 and different Fc fusions in the presence of rh IL-2, rmIL7, rm IL15 for 84 h.
Supernatants from the cell cultures were collected and cells were processed for flow cytometry. a Representative flow cytometry plots of duodenal and
jejunal/ileal WT CD8αα+ γδ IELs following 84 h of culture in the presence of equimolar concentrations of Btnl2-Fc and control mFc fusion proteins.
b, c Suppression of proliferation calculated as the percent difference between the proliferation in the presence of a specific Fc fusion and no Fc fusion,
relative to the proliferation in the absence of Fc fusion. b Suppression of proliferation of duodenal and jejunal/ileal WT CD8αα+ γδ IELs and CD8αβ+ αβ
IELs. c Suppression of proliferation of duodenal and jejunal/ileal Btnl2-KO CD8αα+ γδ IELs and CD8αβ+ αβ IELs. Error bars represent mean ± SEM.
Significance is measured using one-way ANOVA, *p < 0.05, **p < 0.005, ***p < 0.001, ****p < 0.0001, significantly different from mFc fusion protein
control. d, e Cohoused 11-week-old Btnl2-KO and WT mice (n= 4–5, each) were given BrdU at 0.8 mg/mL ad libitum in drinking water for 3 days. BrdU
incorporation was measured by intranuclear staining of γδ IELs from different segments of the small intestine over time. d Representative flow cytometry
plots of BrdU incorporation in ileal CD8αα+ γδ IELs. e BrdU incorporation in CD8αα+ γδ IELs and CD8αβ+ αβ IELs across different segments. Error bars
represent mean ± SEM. Significance is measured using unpaired t-tests assuming similar SD, *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001,
significantly different from WT.
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Fig. 4 Ileal Btnl2-KO γδ IELs display an altered antibacterial response module compared to ileal WT γδ IELs. γδ IELs from duodenum, jejunum, and
ileum of cohoused 11-week-old Btnl2-KO and WT littermates (n= 3–4/genotype, each a pool of 2 mice) were sort-purified as CD45+ TCRβ-TCRγδ+
cells. RNA sequencing was performed, and gene set enrichment analysis using NextBio. Gene ontology (GO) was employed to identify GO biological
processes differentially enriched in Btnl2-KO and WT γδ IELs. a Volcano plot displaying genes differentially regulated between ileal Btnl2-KO and WT γδ
IELs. The Horizontal dashed line indicates FDR= 0.05 and a vertical dashed line indicates |Fold Change |= 1.5. b Hierarchical clustering of top 50
differentially expressed genes between ileal Btnl2-KO and WT γδ IELs; duodenal and jejunal Btnl2-KO and WT γδ IELs were also included as a comparison.
c Gene ontology enrichment analysis of most significantly impaired biological processes in ileal Btnl2-KO γδ IELs compared to ileal WT γδ IELs.
d Hierarchical clustering of top dysregulated antibacterial response genes in ileal Btnl2-KO and WT γδ IELs within the combined top 3 GO processes;
duodenal and jejunal Btnl2-KO and WT γδ IELs were also included as a comparison.
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sampled 3500 γ chains from each sample by 50 bootstrap
replications and observed that the mean Shannon diversity of ileal
Btnl2-KO γ chains was 255.6, significantly higher than 226.8 in
WT (p= 0.0019, T-test) (Fig. 5b). Duodenal and jejunal Btnl2-
KO γδ IELs also showed a trend towards higher diversity in TCR
γ chain compared to WT γδ IELs but the difference was marginal
when contrasted to their ileal counterparts (p= 0.0616 and
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Fig. 5 Ileal Btnl2-KO γδ IELs exhibit more diverse TRGV repertoire compared to ileal WT γδ IELs. γδ IELs from the duodenum, jejunum, and the ileum of
cohoused 11-week-old Btnl2-KO and WT littermates (n= 3–4/genotype, a pool of 2 mice, each) were sort-purified as CD45+ TCRβ-TCRγδ+ cells. Two-
thirds of each sample were processed for deep bulk RNA sequencing and one-third of each sample was pooled per genotype per segment and used for
single-cell sorting and single-cell TCR sequencing. γδ IELs from duodenum, jejunum, and ileum of cohoused 11-week-old Btnl2-KO and WT littermates (n=
8 mice, each) were single-cell sorted and single-cell TCR sequencing analysis of TCR Vγ and TCR Vδ chain usage and CDR3 aminoacid sequences was
performed. a TRGV*J and TRDV*J gene usage in Btnl2-KO and WT γδ IELs. ND not detected. b Top-Diversity estimates for TRG only CDR3 aminoacid
sequences in Btnl2-KO and WT γδ IELs. Shaded areas indicate the 95% confidence interval by 50 bootstrap replicates. Bottom-TRG diversity estimates at
interpolation point 3500, where p value is derived from t-test based on 50 bootstrap replicates. c Diversity estimates for TRD only and paired TRG and TRD
CDR3 aminoacid sequences, respectively, in ileal Btnl2-KO and WT γδ IELs. Shaded areas indicate the 95% confidence interval by 50 bootstrap replicates.
d Diversity 50 (D50) index represented as the number of top unique clones that comprise 50% of the TRGV and TRDV repertoires, respectively,
normalized to the total number of unique clones of duodenal, jejunal and ileal Btnl2-KO and WT γδ IELs.
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chains, Fig. 5b). Although ileal Btnl2-KO γδ IELs had increased
diversity in TCR δ chains (Fig. 5c), Btnl2-KO γδ IELs isolated
from all three segments displayed an increased frequency of
unique clonotypes that comprised 50% of the TRDV repertoire
(duodenum: 19.0% vs. 17.6 %; jejunum: 20.2% vs. 18.6%; and
ileum: 18.5% vs. 18%) (Fig. 5d). In contrast, the overall repertoire
diversity of paired γ/δ chains was marginally altered in ileal
Btnl2-KO γδ IELs (Fig. 5c). Collectively, these results suggested
that the ileal TCR γδ repertoire diversity may be continually
shaped by both host and microbial antigens and metabolites such
that fluctuations in the frequencies of ileal γδ IELs as well as
perturbations in the antimicrobial response module could lead to
significant clonal revisions.
Shared TCR clonotypes display different frequencies in ileal
Btnl2-KO and WT γδ IELs. In addition to unique Btnl2-KO
CDR3γ clones, 19 of the top 20 ileal Btnl2-KO CDR3γ clones
were shared by ileal WT γδ IELs as contracted or expanded
clones, possibly contributing to the TRGV repertoire diversity in
Btnl2-KO compared to WT γδ IELs (Fig. 6a). Overall, ~40% of
CDR3γ clones were shared by Btnl2-KO and WT γδ IELs in each
segment (Supplementary Figure 6a, c). In TCRδ chains, each
segment was characterized by a large number of unique CDR3δ
clones and fewer than 3% shared clones between Btnl2-KO and
WT mice (Supplementary Figure 6b, c). More CDR3γ and
CDR3δ clones were shared by jejunal and ileal γδ IELs (131 vs. 72
and 270 vs. 179, respectively) in Btnl2-KO compared to WT mice,
highlighting the jejunum as a transitional segment in the small
intestine (Supplementary Figure 6d). Btnl2-KO and WT γδ IELs
carrying one CDR3γ/δ pair showed virtually no overlap (less than
0.4%) of their CDR3γ/δ clonal repertoire, emphasizing that
individual mice carry unique γ-chain-δ-chain pairings (Supple-
mentary Figure 7a, b). Nevertheless, up to 13% of CDR3γ/δ
paired clones overlapped between two or all three segments
suggesting the presence of dominant CDR3γ/δ pairs that populate
all segments within individual mice (Supplementary Figure 7c).
We next reconstructed CDR3γ sequences using bulk RNA-seq
data from each individual mouse. The most frequent ileal CDR3γ
clones revealed by single-cell TCR sequencing data were also
found in different individual mice, which suggested that the
single-cell TCR repertoire was an accurate representation of
individual Btnl2-KO and WT CDR3γ diversities (Fig. 6b). The
top ileal Btnl2-KO CDR3γ clones also included TRGV4, TRGV1,
and TRGV7 genes, whereas ileal WT CDR3γ clones carried
TRGV7 almost exclusively (Fig. 6c). For the most frequent
CDR3γ chain (Vγ7-J1, CASWAGYSSGFHKVF), ~70% of IELs
carrying this CDR3γ amino acid sequences were translated from
the same DNA sequence, which could result from clonal
expansion of one progenitor or from recurrent independent
recombinations that pair with distict Vδ sequences in each clone,
while the remainder of the IELs derived from smaller clones with
different DNA sequences (Fig. 6d). Similar convergent Vγ
recombination has been observed for common human Vγ9+
clonotypes, where their abundance has been proposed to be
preconfigured since birth48. Likewise, the most prevalent Vγ7+
chain stemmed from one major and several minor independent
convergent recombination events. These findings highlighted the
presence of public TRGV clonotypes of γδ IELs and suggested
that the paired TRGV/TRDV repertoire diversity may be driven
by the CDR3δ sequence.
γδ IEL transcriptome of shared CDR3γ clones is shaped by
pairing with CDR3δ. To further explore the relationship between
TCR and γδ IEL transcriptome, we performed scRNA-seq on the
same duodenal, jejunal, and ileal γδ IELs we have profiled for
TCR sequencing. We identified nine clusters in each sample
(Supplementary Figure 8a) and the transcriptome of single γδ
IELs in clusters 0, 1, and 3 clearly differentiated between duodenal
and ileal origin with jejunal γδ IELs exhibiting intermediate
transcriptome profiles (Supplementary Figure 8a, b).
Using the top 20 markers detected in each single cell cluster, in
conjunction with molecular signatures described in recent
scRNA-seq and bulk RNAseq reports5,49, we propose γδ IEL
attributes, such as differentiation stage, maturation, and effector
profile, to distinguish among γδ IEL clusters (Supplementary
Figure 8c). In line with previous observations50, clusters 0 and 1
contain mature and highly cytolytic IELs, clusters 2 and 3 include
immature IELs, whereas cluster 4 consists of newly activated IELs
undergoing transcriptional changes such as antigen-mediated
differentiation (Supplementary Figure 8c). The remaining IELs
were subdivided into smaller clusters with specialized effector
profiles such as type I/III interferon responses in cluster 5 (Isg15,
Irf7, Stat1) and subset-specific differentiation stage such as
recently emigrated CD8β+ IEL progenitors in cluster 6 (Klf2,
Thy1, S1pr1, CD8b1, Sell) (Supplementary Figure 8c)6,7,50. With
respect to TRGV distribution, TRGV7 gene usage was dominant
in clusters 0-4, while ileal Btnl2-KO γδ IELs had reduced
frequencies of TRGV7 and higher frequencies of TRGV1 and
TRGV4 in cluster 1 compared to their WT counterparts (40.4%
vs. 45.9%, 15.2% vs. 10.3%, and 13.1% vs. 9.5%, respectively;
Supplementary Figure 8d).
We next examined the distribution of CDR3γ/δ pairings using
the most common ileal CDR3γ, encompassing ~10% of total
CDR3γ clones across different segments and genotypes (Vγ7-J1,
CASWAGYSSGFHKVF). We found that the top CDR3γ chain
was preferentially enriched in cluster 0 of ileal Btnl2-KO γδ IELs
(51.3% vs. 37.2%), which is defined by the largest number of
maturation and cytolytic molecules (Supplementary Figure 8c),
and dominated cluster 1 in WT γδ IELs (47.4% vs 31.5%)
(Fig. 6c). The pairing of the top γ chain bearing the same
nucleotide sequence with distinct CDR3δ sequences shaped the
transcriptome of the pairs, as they are preferentially associated
with specific clusters (Fig. 6d).
Collectively, these RNA-seq and scTCR-seq observations
indicate that Btnl2 deficiency alters the transcriptome as well as
the TRGV/TRDV repertoire of ileal γδ IELs, such that their
antigenic specificities and antibacterial responses are changed.
This report is the first to describe intestinal γδ IEL transcriptome
and TCR repertoire diversity simultaneously at single-cell
resolution, revealing a previously uncharacterized heterogeneity
in duodenal, jejunal and ileal γδ IELs that may account for
compartment-specific immune responses driven by tissue-specific
expression of immune-modulatory molecules.
Btnl2-KO mice exhibit more severe intestinal inflammation in
chronic DSS-induced colitis. Since BTNL2 SNPs have been
associated with increased risk of UC and Crohn’s disease
(CD)31,51–53, we assessed the impact of its deficiency on mucosal
immune responses in the setting of DSS-induced epithelial
injury54,55. Briefly, cohoused Btnl2-KO and WT littermates were
subjected to DSS-induced colitis by administering DSS for 7 days
followed by 8 days of water. While Btnl2-KO and WT mice
exhibited comparable intestinal damage in the early phase of the
disease (day 7), as demonstrated by comparable body weight loss
and increased myeloperoxidase activity (MPO) levels, a bio-
marker of intestinal injury and neutrophilia56 (Fig. 7a, d), we
observed that Btnl2-KO mice exhibited a significant delay in body
weight recovery compared to WT littermates during the repair
phase of colitis (Fig. 7a). The observed delay in recovery was
accompanied by significantly shorter colons, increased granzyme
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A levels, greater histopathological damage, and MPO activity in
the colon compared to WT littermates (Fig. 7b–d, f). Notably,
DSS-treated Btnl2-KO mice had ~2-fold higher levels of pro-
inflammatory cytokines such as IFNγ, IL-6, KC-GRO, TNFα, and
IL-1β in the colon (Fig. 7e). In contrast, MPO activity, a pro-
inflammatory cytokine, and granzyme A levels were not
significantly altered in the ileum of DSS-treated Btnl2-KO mice
compared to WT littermates (Supplementary Figure 9a–c). Cor-
roborating these results, Btnl2 transcripts were increased in the
colon of DSS-treated WT mice, whereas the levels of other family
members, such as Btnl1 and Btnl6, were decreased with DSS

















CDR3γ aa V J KO (%) WT (%)
CASWAGYSSGFHKVF TRGV7*02 TRGJ1*01 9.87 12.4
CSYGLYSSGFHKVF TRGV4*01 TRGJ1*01 3.00 0.78
CASWAYSSGFHKVF TRGV7*02 TRGJ1*01 2.73 2.06
CASWGYSSGFHKVF TRGV7*02 TRGJ1*01 2.46 2.71
CAVWMRYSSGFHKVF TRGV2*01 TRGJ2*01 1.81 0.87
CAVWIGTSWVKIF TRGV1*02 TRGJ4*01 1.60 0.17
CASWAGRSSGFHKVF TRGV7*02 TRGJ1*01 1.54 1.38
CASWAVYSSGFHKVF TRGV7*02 TRGJ1*01 1.31 1.33
CASWAPYSSGFHKVF TRGV7*02 TRGJ1*01 1.25 0.80
CASWVYSSGFHKVF TRGV7*02 TRGJ1*01 1.23 1.02
CASWAGSSGFHKVF TRGV7*02 TRGJ1*01 1.21 0.85
CASWADSSGFHKVF TRGV7*02 TRGJ1*01 0.94 1.14
CASWAGGSSGFHKVF TRGV7*02 TRGJ1*01 0.94 0.61
CASWAGKYSSGFHKVF TRGV7*02 TRGJ1*01 0.94 0
CASWAEYSSGFHKVF TRGV7*02 TRGJ1*01 0.92 0.85
CAVWVYSSGFHKVF TRGV2*01 TRGJ2*01 0.92 1.31
CAVWGYSSGFHKVF TRGV2*01 TRGJ2*01 0.85 0.82
CAVWNSSGFHKVF TRGV2*01 TRGJ2*01 0.81 1.09
CASWAGDSSGFHKVF TRGV7*02 TRGJ1*01 0.79 1.19
CASWALYSSGFHKVF TRGV7*02 TRGJ1*01 0.79 0.61




























Frequency/clone Cells/clone Vγ7 P/N Jγ1
0 0/germline TGT GCC TCC TGG GCT GG AT AGC TCA GGT TTT-
C A S W A S S G F
7.17 311 GCT GG A T
1.48 64 GC G G G A T
1.38 60 GCT GG T T
0.71 31 GCT GG G T
0.58 25 GCT GG C T
0.23 10 GC C G G A T
0.09 4 GC C G G C T
0.09 4 GC G G G G T
0.05 2 GCT GG C T AC
W
T
Frequency/clone Cells/clone Vγ7 P/N Jγ1
0 0/germline TGT GCC TCC TGG GCT GG AT AGC TCA GGT TTT-
C A S W A S S G F
6.77 347 GCT GG A T
0.96 49 GCT T T
0.55 28 GCT GG G T
0.35 18 GCT GG C T
0.29 15  GC A T
0.27 14 GC C G G A T
0.04 2 GC C G G T T
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ileum of DSS-treated suggesting that Btnl2 expression in the
colon may be induced as a feedback regulatory mechanism at the
site of injury to attenuate DSS-triggered inflammation and facil-
itate the recovery process (Supplementary Figure 9d).
Discussion
Emerging research places the Btn/Btnl family of molecules at the
heart of γδ T cell development. Our studies shed light on Btnl2 as
a regulator of ileal γδ IEL maintenance. Specifically, we propose
that Btnl2 acts as a coinhibitory ligand to an unidentified receptor
(s) on γδ IELs and regulates both proliferation and segment-
specific effector profiles of ileal γδ IELs under homeostatic
conditions.
Through our segment-focused approach, we found a temporal
and spatial window during which Btnl2 exerted its functions on
intestinal γδ IELs. ScTCRseq revealed that Vγ7+ IELs dominated
the small intestine of 11-week-old Btnl2-KO and WT mice sug-
gesting that their development was not affected. Although Btnl2
impacted γδ IEL proliferation preferentially in the ileum, its
deficiency reverberated throughout distinct segments of the small
intestine. Specifically, despite the ability of Btnl2 to suppress both
duodenal and jejunal/ileal γδ IEL proliferation in vitro, this was
confined in vivo only to ileal γδ IEL expansion. However, at the
molecular level, Btnl2 deficiency led to an altered Vγ usage among
Vγ7− IELs and similarly altered Vδ usage across all three seg-
ments of the small intestine suggesting overlapping as well as
unique roles for Btnl2 across the distinct segments of the small
intestine. This in turn was accompanied by dysregulated anti-
bacterial module in ileal Btnl2-KO γδ IELs, which may be rele-
vant for mucosal repair and clearance of segment-tropic
pathogenic microbes9.
Consistent with a region-specific effect, duodenal Btnl2-KO
CDR3γ and CDR3γ/δ clonal repertoires were not markedly dif-
ferent from those identified in cohoused WT littermates under-
scoring the ileum as the predominant site of Btnl2-mediated
regulation at steady-state. Importantly, most abundant Vγ clones
in the ileal compartment of individual Btnl2-KO mice included
Vγ1+ and Vγ4+ clones, in contrast to Vγ7+ clones exclusively
enriched in WT mice. Btnl2 may be important for co-regulating
ligands (i.e. Btnl1, Btnl6) of Vγ7+ TCRs during early adulthood.
In support of this dynamic remodeling of the γδ TCRs, Btnl2
deficiency led to different convergent recombination events, such
that pairing of the most common Vγ7+ chain with distinct Vδ
sequences defined the transcriptome profiles of ileal γδ IELs.
Based on the previous studies5,17, one possibility is that site-
specific metabolite levels and/or antigenic pressure led to multiple
independent in situ recombination events, suggesting an adaptive
behavior of γδ IELs towards local environmental antigens. Since
ileal γδ IEL motility along the villi-crypt axis is strictly dependent
on the presence of microbiota14, an impaired antibacterial profile
could also be a consequence of improper localization or ineffec-
tive surveillance of ileal Btnl2-KO γδ IELs. Conversely, loss of
epithelia-expressed Btnl2 could lead to alterations in the local
microbiome, which would then drive reshaping of the TCR
repertoire and antibacterial response module of ileal Btnl2-KO γδ
IELs. Further studies are required to understand how the
reshaped Vγ-Vδ repertoire alongside the defective antibacterial
response module may affect the susceptibility of Btnl2-KO mice
to small intestinal infectious agents.
An acute reliance on Btnl expression at a predefined time has
been proposed for both murine Vγ7+ IEL development and
human Vγ4+/Vδ1+ IEL maintenance5,7. Specifically, Btnl1
expression in adult Btnl1-KO mice could not rescue Vγ7+
development7, whereas mucosal repair and Btnl8 expression
restoration following adherence to a gluten-free diet could not
reconstitute Vγ4+/Vδ1+ IEL subsets in patients with celiac
disease5. In light of these observations, it is tempting to speculate
that Btnl molecules may regulate not only the selective expansion
of tissue-specific Vγ chains in neonates but also their TCR spe-
cificities across distinct tissue compartments in young adults. As
such, segment-biased γδ TCR specificities may be determined by
the choice of dimerization partners among Btnl molecules and
their nuanced spatial and temporal expression in the intestine.
While Btnl1 and Btnl6 jointly affect Vγ7 selection and matura-
tion, there is no known binding partner for Btnl2. In addition, no
other Btnl molecules were induced in the intestine to compensate
for the loss of Btnl2 suggesting that their expression patterns were
not co-regulated, despite being encoded at the same locus. Of the
various family members, structurally, Btnl2 is unique in that it
lacks the antigen-binding B30.2 domain shared by most of the
Btn/Btnl superfamily members57, suggesting that the inhibitory
effect of Btnl2 may depend on the signaling pathways triggered
downstream of engagement of its putative receptor on γδ IELs.
Btnl2 could either homodimerize or heterodimerize with other
intestine-specific Btnls through IgC interactions independent of
B30.2 domains42,58. As a heterodimer, Btnl2 interacting partner
may contribute to the B30.2-driven activation of the heterodimer
and binding to the putative receptor, whereby Btnl2 ligation
would induce the downstream inhibition of proliferation. Btnl1,
Btnl4, and Btnl6 can be candidate binding partners of Btnl2 due
to their similar intestinal expression7. Hence, despite higher
expression on duodenal IECs, Btnl2 may exert more profound
inhibition on ileal γδ IELs due to increased regional expression of
its binding partner on IECs and putative receptor on γδ IELs. As
such, this region-specific interaction may be promoted by local
soluble antigens like bacterial metabolites. Btnl2 could also
function as a receptor antagonist prohibiting the binding of
another Btnl heterodimer to γδ TCR and suppressing γδ IEL
proliferation. Alternatively, as this suppression is only partial,
Btnl2 may indirectly target certain Vγ TCR(s) or TCR specificities
via regulating surface expression of Vγ ligands (i.e. Btnl6 for Vγ7
TCRs)16,59. Further studies are required to address whether Btnl2
can exert its inhibitory effects on γδ IELs across all intestinal
compartments during segment-specific inflammation.
Previous studies showed that γδ T cell depletion induces
greater colonic damage, reduced KGF secretion, increased IFNγ
Fig. 6 Ileal γδ IEL transcriptome of shared Btnl2-KO and WT CDR3γ clones is shaped by pairing with CDR3δ. Ileal γδ IELs from cohoused 11-week-old
Btnl2-KO and WT littermates (pool of 8 mice, each) were single-cell sorted, and single-cell TCR sequencing and single-cell RNA sequencing were
performed. a Top 20 TRG clones (CDR3γ aminoacid sequences listed in order on the right) from ileal Btnl2-KO γδ IELs, which are differentially enriched in
ileal WT γδ IELs. b Top largest CDR3γ clones identified during scTCRseq can be found among individual ileal Btnl2-KO (n= 3) and ileal WT (n= 4)
samples, in which TCR sequences have been reconstructed from bulk RNAseq. Shared clones are highlighted in bold. Each slice represents a different
sample and white slices mark the absence of the CDR3γ clone from the individual sample. c Multiple Vγ7–J1 recombination events converge to the same
top 1 CDR3γ aminoacid sequence (CASWAGYSSGFHKVF) in both ileal Btnl2-KO and ileal WT γδ IELs. d Distribution of top 1 CDR3γ chain (TRGV7*02/
TRGJ1*01, CASWAGYSSGFHKVF; ~10% of total clones) shared by ileal Btnl2-KO and ileal WT γδ IELs among different UMAP clusters. e The pairing of top
1 CDR3γ (CASWAGYSSGFHKVF) with different CDR3δ sequences, listed above the UMAP plot, shapes the transcriptome of the γδ IELs. The number of
clones per pair is denoted below the CDR3δ sequences.
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Fig. 7 Btnl2-KO mice exhibit more severe intestinal inflammation in chronic DSS-induced colitis. Cohoused 15-week-old Btnl2-KO (n= 11) and WT (n=
8) littermates were subjected to 3% DSS-induced colitis for 7 days followed by water for 8 days. Control mice (n= 2–4) received water. a Body weight loss
in cohoused Btnl2-KO and WT littermates calculated as the percent difference between the initial and actual body weight on the above days. Error bars
represent mean ± SEM. Significance is measured using unpaired t-tests assuming similar SD, *p < 0.05, **p < 0.005, ***p < 0.0005, significantly different
from DSS-treatedWT mice. b Colon length of water- and DSS-treated Btnl2-KO andWTmice on day 15. c H&E histological sections and a pathological score
of the colon from water- and DSS-treated Btnl2-KO and WT mice. Scale bars are 200 μm (WT/water), 250 μm (Btnl2-KO/water), 500 μm (WT/DSS and
Btnl2-KO/DSS). d Myeloperoxidase (MPO) activity in colon homogenates of water- and DSS-treated Btnl2-KO and WT mice. e Levels of pro-inflammatory
cytokines in colon homogenates of water and DSS-treated Btnl2-KO and WT mice. f Granzyme A mRNA levels in colon homogenates of water- and DSS-
treated Btnl2-KO and WT mice, normalized to β2m. Error bars represent mean ± SEM. Significance is measured using unpaired t-tests assuming similar SD,
*p < 0.05. g Btnl1/2/6 mRNA levels in the colon of water- and DSS-treated WT mice, normalized to β2m. Error bars represent mean ± SEM. Significance is
measured using one-way ANOVA, *p < 0.05, **p < 0.005, ***p < 0.0005.
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production by αβ T cells and decreased IEC proliferation during
DSS-induced colitis, suggesting that γδ IELs can promote
mucosal repair following epithelial injury12,60. Conversely,
impaired IL-10 production by Tregs leads to uncontrolled γδ IEL
proliferation and spontaneous colitis in Pdk1f/f; CD4cre mice,
supporting a proinflammatory role for γδ IELs in the colon61.
Btnl2 expression is upregulated in the distal colon during DSS-
induced colitis and Btnl2-KO colitic mice exhibit a delay in
recovery during the mucosal repair phase of the disease, poten-
tially due to γδ IEL-dependent and -independent (i.e. Tregs,
proinflammatory helper T cells) mechanisms to controlling the
damage caused by epithelial injury. Interestingly, Btnl1 and Btnl6
transcripts were downregulated in Btnl2-KO colitic mice, con-
firming previous reports in which Btnl1/6 transcripts were shown
to be significantly reduced in the distal colon of Muc2-KO mice
and BTNL8 expression was diminished or lost in colonic and
duodenal biopsies of patients with UC and celiac disease,
respectively5,32. Hence, we speculate that IECs upregulate Btnl2
expression in response to environmental stress factors to limit the
damage-induced expansion of γδ IELs and induce the release of
antibacterial molecules. As such, our findings support the idea
that close interaction between γδ IELs and epithelium-specific
Btnl molecules throughout the small and large intestines drives
their proliferation and function in homeostatic and inflammatory
settings14.
In conclusion, we have unveiled a novel role for Btnl2 in
regulating the expansion of ileal γδ IELs, sculpting of their Vγ
and Vγ-Vδ TCR specificities and altering their antibacterial
response module. Our scRNAseq and scTCRseq surveys revealed
a highly dynamic γδ IEL compartment finely adapted to envir-
onmental cues of each segment of the small intestine during
adulthood. Further studies are required to establish whether the
timing and choice of intestinal Btnl heteromers drive the site-
specific functions of γδ IELs in intestinal immune disorders.
Taken together, these studies suggest that Btnl-mediated targeting
of γδ IEL development and maintenance may help dissect their
immunological functions in intestinal diseases with gut segment-
specific manifestations.
Materials and methods
Mice. Eight- to twelve-week-old female C57BL/6 mice were obtained from Jackson
Laboratory. Btnl2-KO mice on a C57BL/6 background were generated and main-
tained at Regeneron Pharmaceuticals Inc. using the VelociGene technology62,63.
Briefly, a LacZ cassette was inserted in-frame with the start codon followed by a
selection cassette that disrupted the transcription of the Btnl2 gene resulting in a
null allele. Heterozygous mice were interbred to produce homozygous KO and WT
littermates. Btnl2 expression pattern was confirmed by β-galactosidase staining and
Btnl2 targeted deletion was measured by quantitative RT-PCR and RNA sequen-
cing of the small intestine. Btnl2-KO and WT female mice were used at 10-17
weeks of age for all the experiments except when otherwise indicated. Female
littermates were cohoused after weaning for several weeks and assigned randomly
to experimental groups in disease settings. All animals were maintained under
pathogen-free conditions and experiments were performed according to protocols
approved by the Institutional Animal Care and Use Committee at Regeneron
Pharmaceuticals Inc.
Isolation of intestinal epithelial cells (IECs), intraepithelial lymphocytes
(IELs), and lamina propria lymphocytes (LPLs). The small intestine was divided
into three equal segments and lymphocyte isolation proceeded as described
previously64. Briefly, to isolate IEC and IEL fractions, the small intestine was cut
into 2 cm pieces and incubated in HBSS containing 5 mM EDTA, 10 mM HEPES
and 2% fetal calf serum (FCS) twice for 15 min at 37 °C with shaking at 150 rpm.
After vigorous vortexing, the intestinal pieces were washed over 100 μm cell
strainer and centrifuged on a 40%/80% Percoll gradient (GE Healthcare) at 2500
rpm for 20 min at 20 °C. The top layer containing IECs was collected, washed, and
resuspended in Trizol for RNA extraction. IEL fraction was collected from the
interface, washed, and resuspended in Miltenyi MACS buffer. Following IEL iso-
lation, LPLs were isolated from intestinal pieces by incubation in HBSS w/o Ca2
+/Mg2+ supplemented with 50 UmL−1 Collagenase D (Roche), 0.25 mgmL−1
DNase I (Sigma-Aldrich), 50 UmL−1 Dispase (Corning), and 5% FCS for two
rounds of 25 min at 37 °C with shaking at 150 rpm. Cells were centrifuged on a
40%/80% Percoll gradient (GE Healthcare) and LPLs were collected from the
interface, washed, and resuspended in MACS buffer for immediate surface cell
staining.
Mesenteric lymph node and Peyer’s Patch immunophenotyping. Peyer’s Pat-
ches were collected from the whole small intestine, washed with ice-cold DPBS, and
incubated with 50 UmL−1 Collagenase D (Roche), 0.25 mgmL−1 DNase I (Sigma-
Aldrich), 50 UmL−1 Dispase (Corning), and 5% FCS for 25 min at 37 °C with
shaking at 150 rpm. Mesenteric lymph nodes were minced in HBSS with Ca2+/Mg2
+containing 15 UmL−1 Collagenase D (Roche) and 50 μg mL−1 DNase I (Sigma-
Aldrich), and incubated for 20 min at 37 °C without shaking. Cells were resus-
pended in MACS buffer for immediate surface staining.
Flow cytometry. Flow cytometry antibodies were purchased from Biolegend (US),
BD Biosciences (US), TONBO Biosciences (US), eBioscience (US) and Thermo-
Fischer (US). Dead cells were excluded using LIVE/DEAD fixable blue dead cell
stain (Thermo Fischer Scientific, Cat#L23105). Fc receptors were blocked using
purified anti-mouse CD16/32 (BD Pharmigen, Clone 2.4G2, Cat#553142) and 2%
each of normal mouse serum (Jackson ImmunoResearch, Cat#015-000-120), rat
serum (Jackson ImmunoResearch, Cat#012-000-120) and hamster serum (Jackson
ImmunoResearch, Cat#007-000-120). The following antibodies were used for the
staining according to manufacturer’s instructions: CD45-BV510 (Biolegend,
Clone#30-F11, Cat#103138), CD8α-AF700 (Biolegend, Clone#53-6.7, Cat#100730),
CD8β-PerCP/Cy5.5 (Biolegend, Clone#YTS156.7.7, Cat#126610), TCRβ-BV711
(Biolegend, Clone#H57-597, Cat#109243), TCRβ-APC/Cy7 (Biolegend, Clo-
ne#H57-597, Cat#109220), TCRγ/δ-PE/Cy7 (Biolegend, Clone#GL3, Cat#118124),
CD11b-APC/Cy7 (Biolegend, Clone#M1/70, Cat#101226), CD11c-APC/Cy7
(Biolegend, Clone#N418, Cat#117324), CD11c-AF700 (Biolegend, Clone#N418,
Cat#117320), CD11c-PE/Cy7 (Biolegend, Clone#N418, Cat#117318), Gr1-APC/
Cy7 (Biolegend, Clone#RB6-8C5, Cat#108424), B220-APC/Cy7 (Biolegend, Clo-
ne#RA3-6B2, Cat#103224), B220-AF700 (Biolegend, Clone#RA3-6B2,
Cat#103232), B220-BV650 (Biolegend, Clone#RA3-6B2, Cat#103241), NK1.1-
APC/Cy7 (Biolegend, Clone#PK136, Cat#108724), MHCII-BV421 (Biolegend,
Clone#M5/114.15.2, Cat#107632), Ly6C-PerCP/Cy5.5 (Biolegend, Clone#HK1.4,
Cat#128012), CD64-PE (Biolegend, Clone#X54-5/7.1, Cat#139304), CD103-FITC
(Biolegend, Clone#2E7, Cat#121420), CX3CR1-Biotin (Biolegend, Clone#-
SA011F11, Cat#149018), Streptavidin-PE/Dazzle 594 (Biolegend, Cat#405248),
NKp46-PE/Dazzle594 (Biolegend, Clone#29A1.4, Cat#137630), CD4-PerCP/Cy5.5
(Biolegend, Clone#GK1.5, Cat#100434), CD4-VF450 (Tonbo Biosciences, Clo-
ne#GK1.5, Cat#75-0041-U100), c-KIT-PE-Cy7 (Biolegend, Clone#ACK2,
Cat#135112), CD44-APC/Cy7 (Biolegend, Clone#IM7, Cat#103028), CD44-BV650
(Biolegend, Clone#IM7, Cat#103049), RORγt-APC (eBiosciences, Clone#AFKJS-9,
Cat#17-6988-82), FoxP3-AF700 (eBioscience, Clone#FJK-16s, Cat#56-5773-82),
FoxP3-eF450 (eBioscience, Clone#FJK-16s, Cat#48-5773-82), LegendScreen Mouse
PE kit (Biolegend, Cat#700005). For intranuclear staining, cells were incubated
with fixable viability dye and surface markers prior to fixation and permeabilization
using the FoxP3/Transcription factor fixation and permeabilization kit
(eBioscience) according to manufacturer’s instructions.
BrdU (Sigma-Aldrich) incorporation was assessed 3 days after continuous
administration in drinking water dissolved at 0.8 mg mL−1 in 3% sucrose. Briefly,
IELs were fixed with BD Cytofix/Cytoperm™ for 20 min at 20 °C, washed and
incubated with 1x DPBS supplemented with Ca2+/Mg2+, 10% FCS, and 10%
DMSO for 10 min at 20 °C. Cells were re-fixed with BD Cytofix/Cytoperm™ for
5 min at 20 °C, washed and incubated with 0.5 mg mL−1 DNAse I (Sigma-Aldrich)
for 1 hr at 37 °C. Cells were stained with BrdU-AF647 (MoBU-1) (Thermo Fisher
Scientific, Clone# MoBU-1, Cat#B35133) at 20 °C, washed, and resuspended for
acquisition.
Flow cytometry was performed on the LSRFortessa X-20 instrument (BD
Biosciences), data were analyzed using FlowJo software (BD Biosciences) and
plotted using GraphPad Prism™ (GraphPad Software, Inc.). Representative gating
strategies for flow cytometry are provided in Supplementary Figure 10.
In vitro IEL proliferation assay. Total 96-well flat-bottom plates were coated
overnight with 1 μg mL−1 purified anti-mouse CD3ε (Tonbo Biosciences, 145-
2C11, Cat#70-0031-M001) and 60 pmoles of mouse Btnl2-Fc, PDL1-Fc or mFc
(Adipogen Life Sciences) at 4 °C and washed twice with DPBS before adding IELs
to the cultures. Freshly isolated IELs were labeled with CellTrace CFSE Cell Pro-
liferation dye according to the manufacturer’s instructions (Thermo Fischer Sci-
entific, Cat#C34554). CFSE-labeled IELs were plated at 200,000 cells per well in
RPMI 1640 supplemented with 10% FCS, 1% Pen/Strep, 2% HEPES, 1% Gluta-
mine, 1% nonessential amino acids, 1% sodium pyruvate, 0.1% β-mercapto-ethanol
(Gibco), recombinant mouse IL-7 (10 ng mL−1, R&D), recombinant mouse IL-15
(10 ng mL−1, R&D) and recombinant human IL-2 (10 ng mL−1, Peprotech). Cells
were incubated for 72–96 h at 37 °C in 5% CO2 prior to analysis.
In vitro CD4+ T cell proliferation assay. Total 96-well flat-bottom plates were
coated overnight with 1 μg mL−1 purified anti-mouse CD3ε (Tonbo Biosciences,
145-2C11, Cat#70-0031-M001), 1 μg mL−1 purified anti-mouse CD28 (Tonbo
Biosciences, 37.51, Cat#70-0281-U500), and 60 pmoles of mouse Btnl2-Fc, PDL1-
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Fc, PDL2-Fc or mFc (Adipogen Life Sciences) at 4 °C and washed twice with DPBS
before adding CD4+ T cells to the cultures. CD4+ T cells were enriched from
pooled spleen and lymph nodes using mouse CD4 (L3T4) microbeads (Miltenyi
Biotec) and labeled with CellTrace CFSE Cell Proliferation dye (Thermo Fischer
Scientific, Cat#C34554). CFSE-labeled CD4+ T cells were plated at 80,000–100,000
cells per well in RPMI 1640 supplemented with 10% FCS, Pen/Strep, 2% HEPES,
1% Glutamine, 1% nonessential amino acids, 1% sodium pyruvate and 0.1% β-
mercapto-ethanol (Gibco). Cells were incubated for 72 h at 37 °C in 5% CO2 prior
to analysis.
DSS-induced model of colitis. Fourteen-twenty-week-old cohoused female Btnl2-
KO and WT mice with an average body weight greater than 23 g were given 3%
DSS (Sigma-Aldrich) in drinking water for 6–7 days followed by distilled water for
up to 10 days. Control group received only distilled water for the duration of the
study. Mice were weighed and monitored daily for clinical signs of colitis (e.g. stool
consistency, fecal blood). On day 15, mice were euthanized, and colon length was
measured.
Generation of colon and ileal homogenates and measurement of cytokines
and myeloperoxidase (MPO) activity. Total 6 mm pieces of distal colon or
terminal ileum were placed in T-per buffer (Thermo Fisher Scientific) containing
1× Halt Protease Inhibitor Cocktail (Thermo Fisher Scientific), 0.5 M EDTA
solution (Thermo Fisher Scientific), and two 3mm tungsten carbide beads (Qia-
gen). Tissues were disrupted in TissueLyser II (Qiagen) for 10 min at an oscillation
frequency of 27.5 Hz. Generated tissue homogenates were centrifuged at 15000 rcf
for 10 min at 4 °C and the supernatants were collected into deep 96-well plates.
Protein assay dye (BioRad) was used to quantify total protein content using
Bradford protein assay according to the manufacturer’s instructions. Cytokine
concentrations were measured using V-PLEX Plus Proinflammatory Panel 1 mouse
kit according to the manufacturer’s instructions (Meso Scale Diagnostics).
Absorbance was measured on the Meso SECTOR S600 instrument (Meso Scale
Diagnostics). Myeloperoxidase (MPO) activity was measured using a mouse MPO
ELISA kit according to the manufacturer’s instructions (Hycult Biotech). Absor-
bance was measured on the SpectraMax i3x instrument (Molecular Devices). Data
analysis was performed using GraphPad Prism™ (GraphPad Software, Inc.).
Cytokine and MPO levels were normalized to total protein content.
Histology. Total 3 cm pieces of duodenum, jejunum, ileum, and colon were pre-
pared as swiss rolls, fixed in 10% buffered formalin, embedded in paraffin, sec-
tioned at 5 μm and H&E stained. Histology was performed by HistoWiz Inc.
(histowiz.com) using a Standard Operating Procedure and fully automated work-
flow. After staining, sections were dehydrated and film coverslipped using a
TissueTek-Prisma and Coverslipper (Sakura). Whole slide scanning (40x) was
performed on an Aperio AT2 (Leica Biosystems). Histopathological scoring was
performed by an evaluator blinded to genotype, group assignment, and experi-
mental outcome. The following features were evaluated for DSS-induced injury and
scored based on previous published criteria:65 degree of inflammation in lamina
propria, goblet cell loss, abnormal crypts, presence of crypt abscesses, mucosal
erosion, and ulceration, submucosal spread to transmural involvement, number of
neutrophils. Each parameter received a score from 0 to 4 with a maximum
cumulative score of 17. Mucosal lesions in unchallenged mice were scored as
described previously:66 0, normal; 1, mild sloughing of epithelial cells; 2, moderate
sloughing of epithelial cells; 3, severe mucosal edema; 4, extensive mucosal injury.
Data analysis was performed using GraphPad Prism™.
Quantitative PCR. RNA was isolated from IECs derived from duodenum, jeju-
num, ileum, and colon from cohoused unchallenged Btnl2-KO and WT mice. RNA
was extracted from distal colon and terminal ileum from cohoused, water- and
DSS-treated Btnl2-KO and WT mice. RNA was purified on Kingfisher flex
(Thermo Fisher Scientific) using the MagMAX-96 for Microarrays Total RNA
isolation kit (Thermo Fisher Scientific) with an additional DNAse I (Sigma-
Aldrich) step added between the first and second washes. cDNA synthesis was
performed using SuperScript® VILO™ Master mix (Thermo Fisher Scientific)
according to the manufacturer’s instructions. qPCR was performed using MyTaq™
Mix (Bioline) and assay mix (Thermo Fisher Scientific or LGC BioSearch). Probes
for each gene are listed in Table 1. qPCR was run on an ABI 7900HT Fast Real-
Time PCR System with a 384-well block module and automation accessory
(Thermo Fisher Scientific). Gene expression was normalized to β2 m and differ-
ences were determined using the 2ΔC(t) calculation.
Single-cell RNA sequencing of γδ IELs. Following IEL isolation, cells were stained
with LIVE/DEAD fixable blue dead cell stain as per the manufacturer’s instructions
(Thermo Fisher Scientific, Cat#L23105). Fc receptors were blocked using purified
anti-mouse CD16/32 (BD Pharmigen, Clone 2.4G2, Cat#553142) and 2% each of
normal mouse serum (Jackson ImmunoResearch, Cat#015-000-120), rat serum
(Jackson ImmunoResearch, Cat#012-000-120) and hamster serum (Jackson
ImmunoResearch, Cat#007-000-120) and cells were stained using the following
antibodies: CD45-BV510 (Biolegend, Clone#30-F11, Cat#103138), CD8α-AF700
(Biolegend, Clone#53-6.7, Cat#100730), CD8β-PerCP/Cy5.5 (Biolegend, Clo-
ne#YTS156.7.7, Cat#126610), TCRβ-BV711 (Biolegend, Clone#H57-597,
Cat#109243), TCRγδ-PE/Cy7 (Biolegend, Clone#GL3, Cat#118124). Two mice
were pooled per each sample. γδ IELs were sorted from each sample using MoFlo
Astrios EQ (Beckman Coulter). Two-thirds of each sample were resuspended in
RNA Lysis Buffer (Zymo Research) and processed for bulk RNA sequencing. One-
third of each sample was pooled per segment of the small intestine per genotype,
resuspended in PBS with 0.04% BSA, and loaded on a Chromium Single Cell
Instrument (10X Genomics). RNAseq and V(D)J libraries were prepared using
Chromium Single Cell 5’ Library, Gel Beads & Multiplex Kit (10X Genomics). After
amplification, cDNA was divided into RNAseq and V(D)J library aliquots. To
enrich the V(D)J library aliquot for γδ TCRs, cDNA was divided into two 10 ng
aliquots and amplified in two rounds using internally designed primers. In parti-
cular, the following primers were used for the first round of amplification: MP147
for short R1 (ACACTCTTTCCCTACACGACGC), MP371 for mouse TRGC1-3
(/5Biosg/TTCCTGGGAGTCCAGGATRGTATTG), MP 372 for mouse TRGC4
(/5Biosg/CACCCTTATGACTTCAGGAAAGAACTTT), and MP369 for mouse
TRDC (/5Biosg/TTCCACAATCTTCTTGGATGATCTGAG). For the second
round of amplification, 20 ng aliquots from the first round were further amplified
using MP147 for short R1 (ACACTCTTTCCCTACACGACGC), MP373 a nested
R2 plus mouse TRGC(GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTG
TCCCAGYCTTATGGAGATTTGT), and MP370 a nested R2 plus mouse TRDC
(GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTAGTCACCTCTTTAG
GGTAGAAATCTT). V(D)J libraries were prepared from 25 ng of each mTRGC
and mTRDC amplified cDNA. Paired-end sequencing was performed on Illumina
NextSeq500 for RNAseq libraries (Read 1 26 bp for a unique molecular identifier
(UMI) and cell barcode, 8 bp i7 sample index, 0 bp i5, and Read 2 55 bp transcript
read) and V(D)J libraries (Read 1 150 bp, 8 bp i7 sample index, 0 bp i5, and Read 2
150 bp read). For RNAseq libraries, Cell Ranger Single-Cell Software Suite (10X
Genomics, v2.2.0) was used to perform sample de-multiplexing, alignment, filter-
ing, and UMI counting. The mouse mm 10 genome assembly and RefSeq gene
model for mouse were used for the alignment. For V(D)J libraries, Cell Ranger
Single-Cell Software Suite (10X Genomics, v2.2.0) was used to perform sample de-
multiplexing, de novo assembly of read pairs into contigs, align and annotate
contigs against all the germline segment V(D)J reference sequences from IMGT,
label and locate CDR3 regions, group clonotypes.
Single-cell RNA sequencing data analysis. scRNAseq data were analyzed using
Seurat R package67. Cells with fewer than 500 genes or more than 10% of mito-
chondrial RNA content were excluded during the quality control (QC) step. The
remaining cells underwent dimension reduction by PCA on the highly variable
genes. Data were further reduced to the 2D space on the first 20 PCs using uniform
manifold approximation and projection (UMAP). Cell clusters were determined
using a graph-based unbiased clustering approach implemented in Seurat. Positive
markers defining each cluster were identified using the Wilcoxon rank-sum test. Six
representative markers were selected for each cluster to visualize in heatmaps.
Single-cell TCR sequencing data analysis. After V(D)J sequences were assem-
bled and annotated, only productive γ and δ TCR sequences were kept. Two TCR
diversity metrics (i.e. species richness and exponential of Shannon entropy) were
estimated for each sample using iNEXT R package47,68. Species richness measured
total unique clone numbers, whereas the Shannon index computed the uncertainty
in predicting the identity of a sequence taken at random from the dataset. Both
interpolated and extrapolated diversities were estimated, and a 95% confidence
interval was based on 50 bootstraps. TCR repertoires were visualized using the
Treemap R package (https://CRAN.R-project.org/package=treemap). Downstream
Table 1 RT-PCR Probes for select genes.
Gene Forward Reverse Probe
BTNL2 GGATTGCCCACGGTATAGTC AGGACCGACCACTCTGAAG TATCTGGCGTGGCTGCCTCCTT
BTNL1 GGTGCAGATGCCGGAATACAG GCCACACTTCCCATGTCAATG CAGGACCCAGATGGTGAGACAAGC
BTNL6 GAGGCCATCTTGGAACTGAA CCACCGTCTTCTGGACCTTT TGGCAGCAATGGGCTCTGTCC
b2m GGGAAGCCGAACATACTGAACTG CCCGTTCTTCAGCATTTGGATTTC ACGTAACACAGTTCCACCCGCCT
Gzma GGCGCTTTGATTGAAAAGAACTG TGTTCTGGCTCCTTATTGATTGAG TGACTGCTGCCCACTGTAACGTGG
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TCR analysis such as V(D)J usage, shared TCR, and integration of TCR and RNA-
seq was performed using customized R scripts (available upon request).
Bulk RNA-sequencing and data analysis. cDNA was synthesized and amplified
(16-cycle PCR) from 5 ng total RNA using SMARTer® Ultra® Low RNA Kit
(Clontech). Nextera XT library prep kit (Illumina) was used to generate the final
sequencing library (12 PCR cycles performed to amplify libraries) using 1 ng of
cDNA as the input. The amplified libraries were size-selected at 400 to 600 bp.
Sequencing was performed on Illumina HiSeq® 2500 (Illumina) by multiplexed
paired-read run with 2 × 100 cycles. The sequencing reads were mapped to the
customized mouse genome using ArrayStudio (OmicSoft). Sense-strand exon reads
were used to quantify the gene expression level by RSEM algorithm implemented
in ArrayStudio. Genes were flagged as detectable with a minimum of 10 reads.
Differentially expressed gene analysis was performed using Deseq269. Genes with
fold change | > 1.5 | and FDR < 0.05 were considered significantly differentially
expressed. The differentially expressed genes were subjected to pathway enrich-
ment analysis using the Running Fish exact test in NextBio (www.nextbio.com).
TCR hypervariable-region sequences were reconstructed using TRUST70.
Statistics and reproducibility. Statistical significance (p values) within the groups
was determined by using one of the following statistical tests: unpaired t-tests
assuming similar SD; one-way ANOVA with Tukey’s multiple comparison post-
test; or ordinary two-way ANOVA with Sidak’s multiple comparison post-test,
*p < 0.05, **p < 0.005, ***p < 0.0005. P values of < 0.05 were considered significant.
Statistical analyses were performed with Graphpad Prism 8. Samples were defined
as biological replicates and no technical replicates were used to generate graphs.
Each experiment was repeated at least three times, sample sizes and numbers and
the statistical test used were indicated in each figure legend.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The single-cell RNA-seq, TCR seq, and bulk RNA-seq data have been deposited to Gene
Expression Omnibus under accession number (GSE178273). Source data can be found in
Supplementary Data 1.
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